Physician profile
William Warner
NPI 1265403463
$3,574.27
in general payments reported to CMS, 2019-2025
25 companies · $505 in 2025
The $505 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.52 · 2021: $1,143 · 2022: $712 · 2023: $595 · 2024: $552 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,628 · Travel and Lodging: $24.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,628.49 |
| Travel and Lodging | $24.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,226.96 | 2021-2024 | Bulkamid, Axonics |
| Boston Scientific Corporation | $788.62 | 2019-2025 | Solyx Sis System, Advantage System, Capio Rp |
| Abbvie INC. | $446.52 | 2022-2025 | Botox |
| Caldera Medical, INC | $323.53 | 2023-2025 | Desara |
| Medtronic, INC. | $155.48 | 2022-2025 | Altaviva |
| Coloplast Corp | $91.45 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $61.12 | 2022-2023 | Seglentis, Livalo |
| Ethicon US, LLC | $54.56 | 2025 | Vistaseal |
| Exeltis, USA INC. | $52.52 | 2022-2023 | Slynd |
| Biogen, INC. | $47.73 | 2025 | Zurzuvae |
| Intuitive Surgical, INC. | $44.20 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.59 | 2022-2023 | |
| Organon LLC | $33.85 | 2024 | |
| Valencia Technologies Corporation | $26.82 | 2025 | Ecoin Device Kit |
| Pfizer INC. | $19.87 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $18.87 | 2025 | Eclipse |
| Astellas Pharma US INC | $18.63 | 2022 | |
| Exact Sciences Corporation | $18.26 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $17.39 | 2023 | Arexvy, Shingrix |
| Allergan, INC. | $16.31 | 2021 | |
| Mayne Pharma Commercial LLC | $15.68 | 2023 | |
| Idorsia Pharmaceuticals US INC | $14.27 | 2022 | |
| Sumitomo Pharma America, INC. | $13.91 | 2025 | Myfembree |
| Novo Nordisk INC | $13.23 | 2023 | Rybelsus, Ozempic |
| Shield Therapeutics INC | $12.90 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.